← HB3834 bill details

Substantive final action

HB3834

House: THIRD READING

Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Passed House March 11, 2026⭐ Substantive final action

68Yea
23Nay
0Not voting
8Absent

Yea (68)

Nay (23)

Absent (8)

Source provenance